Cargando…
Injectable decellularized nucleus pulposus tissue exhibits neuroinhibitory properties
BACKGROUND: Chronic low back pain (LBP) is a leading cause of disability, but treatments for LBP are limited. Degeneration of the intervertebral disc due to loss of neuroinhibitory sulfated glycosaminoglycans (sGAGs) allows nerves from dorsal root ganglia to grow into the core of the disc. Treatment...
Autores principales: | Piening, Logan M., Lillyman, David J., Lee, Fei San, Lozano, Alvaro Moreno, Miles, Jeremy R., Wachs, Rebecca A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8966883/ https://www.ncbi.nlm.nih.gov/pubmed/35386760 http://dx.doi.org/10.1002/jsp2.1187 |
Ejemplares similares
-
An injectable nucleus pulposus cell-modified decellularized scaffold: biocompatible material for prevention of disc degeneration
por: Shan, Zhi, et al.
Publicado: (2017) -
Axial hypersensitivity is associated with aberrant nerve sprouting in a novel model of disc degeneration in female Sprague Dawley rats
por: Lillyman, David J., et al.
Publicado: (2022) -
Extracellular Alpha-Synuclein Promotes a Neuroinhibitory Secretory Phenotype in Astrocytes
por: Di Marco Vieira, Bruno, et al.
Publicado: (2020) -
Development of 2-D and 3-D culture platforms derived from decellularized nucleus pulposus
por: Herrera Quijano, Marco A., et al.
Publicado: (2022) -
Rat tail models for the assessment of injectable nucleus pulposus regeneration strategies
por: Barcellona, Marcos N., et al.
Publicado: (2022)